Kohjin Bio Co., Ltd. (TYO:177A)

Kohjin Bio Statistics

Total Valuation

Kohjin Bio has a market cap or net worth of JPY 6.23 billion. The enterprise value is 5.88 billion.

Market Cap	6.23B
Enterprise Value	5.88B

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	Mar 30, 2026

Share Statistics

Kohjin Bio has 5.11 million shares outstanding. The number of shares has increased by 6.31% in one year.

Current Share Class	5.11M
Shares Outstanding	5.11M
Shares Change (YoY)	+6.31%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	55.34%
Owned by Institutions (%)	16.65%
Float	1.54M

Valuation Ratios

The trailing PE ratio is 11.19.

PE Ratio	11.19
Forward PE	n/a
PS Ratio	1.23
PB Ratio	1.05
P/TBV Ratio	1.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	10.55
EV / Sales	1.16
EV / EBITDA	5.09
EV / EBIT	7.85
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.32.

Current Ratio	1.86
Quick Ratio	1.40
Debt / Equity	0.32
Debt / EBITDA	1.72
Debt / FCF	n/a
Interest Coverage	19.00

Financial Efficiency

Return on equity (ROE) is 9.79% and return on invested capital (ROIC) is 10.26%.

Return on Equity (ROE)	9.79%
Return on Assets (ROA)	4.99%
Return on Invested Capital (ROIC)	10.26%
Return on Capital Employed (ROCE)	10.71%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	30.38M
Profits Per Employee	3.34M
Employee Count	167
Asset Turnover	0.58
Inventory Turnover	3.51

Taxes

In the past 12 months, Kohjin Bio has paid 154.00 million in taxes.

Income Tax	154.00M
Effective Tax Rate	21.66%

Stock Price Statistics

The stock price has decreased by -26.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-26.12%
50-Day Moving Average	1,323.48
200-Day Moving Average	1,558.40
Relative Strength Index (RSI)	43.78
Average Volume (20 Days)	8,180

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kohjin Bio had revenue of JPY 5.07 billion and earned 557.00 million in profits. Earnings per share was 108.97.

Revenue	5.07B
Gross Profit	2.18B
Operating Income	703.00M
Pretax Income	711.00M
Net Income	557.00M
EBITDA	1.11B
EBIT	703.00M
Earnings Per Share (EPS)	108.97

Balance Sheet

The company has 2.27 billion in cash and 1.91 billion in debt, with a net cash position of 356.00 million or 69.65 per share.

Cash & Cash Equivalents	2.27B
Total Debt	1.91B
Net Cash	356.00M
Net Cash Per Share	69.65
Equity (Book Value)	5.92B
Book Value Per Share	1,157.37
Working Capital	2.06B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 42.98%, with operating and profit margins of 13.85% and 10.98%.

Gross Margin	42.98%
Operating Margin	13.85%
Pretax Margin	14.01%
Profit Margin	10.98%
EBITDA Margin	21.85%
EBIT Margin	13.85%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 25.00, which amounts to a dividend yield of 2.05%.

Dividend Per Share	25.00
Dividend Yield	2.05%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-6.31%
Shareholder Yield	-4.22%
Earnings Yield	8.94%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Kohjin Bio has an Altman Z-Score of 3.29 and a Piotroski F-Score of 3.

Altman Z-Score	3.29
Piotroski F-Score	3